Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

UK-Norwegian Collaboration Aims to Develop a New Living Skin Equivalent Model

Published: Tuesday, May 21, 2013
Last Updated: Monday, May 20, 2013
Bookmark and Share
New in vitro human living skin equivalent model for testing inflammatory responses.

Epistem and ScandiDerma have announced that they aim to develop a new in vitro human living skin equivalent model for testing inflammatory responses.

This is a novel method that will add to the field of dermatological testing as a whole and help create more activity in extracting high value compounds from biomass.

The collaboration is made possible through the UK's innovation agency, the Technology Strategy Board, and Innovation Norway following a successful application for funding in the "Sustainable high value chemical manufacture through industrial biotechnology" competition.

Matthew Walls, Epistem CEO commented "The collaboration with ScandiDerma presents an exciting opportunity to leverage Epistem's strong scientific background in skin biology and inflammation to address the shortage of robust human dermatology models for testing inflammatory responses.

"For ScandiDerma this is an important milestone in building up our competence around test-systems and how to rapidly determine good lead candidates from our bioprospecting activities" Ingebjorg Pernille Nedal, CEO ScandiDerma.

The project will last from May 2013 to March 2014 and will run from the project leader Epistem's facilities in Manchester UK and ScandiDerma's facilities in Barents Biocenter, Tromso, Norway.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Epistem and CRT Announce Agreement
Agreement for the use of patient derived leukemic Primagraft samples.
Friday, May 01, 2015
Epistem Announces the Successful Evaluation of New RNA-AMP™ Technology
A highly sensitive and reproducible method to derive cDNA from picogram to nanogram quantities of RNA.
Friday, February 13, 2015
Epistem, Global Health Investment Fund Sign Collaborative Funding Agreement
Agreement will see GHIF support the roll-out of Epistem's Genedrive® molecular diagnostic platform.
Wednesday, July 23, 2014
Epistem Announces Further Partnership With The University of Manchester
Partnership will allow the Company to expand its existing range of wound healing models.
Tuesday, April 22, 2014
Epistem Announces Opening of US Laboratory
Laboratory will support the expansion of Epistem's contract research division.
Thursday, March 06, 2014
Epistem Announces Executive Board Appointments
Dr Allan Brown joins the Board as Chief Operating Officer of the Diagnostics division of the Company, with effect from 1st February, 2014.
Monday, January 27, 2014
Epistem Announces Evaluation of Genedrive® for Pathogen Detection
Epistem in cooperative agreement with the US Air Force and with Johns Hopkins University.
Thursday, January 16, 2014
Epistem Tuberculosis Test Gains CE-IVD Registration
Epistem to place its TB test and Genedrive™ units for sale in the EEA member state markets.
Thursday, July 05, 2012
Epistem Announces Collaboration with GSK
Three year biomarker collaboration in the field of fibrosis research.
Wednesday, March 14, 2012
Epistem Signs Tuberculosis Channel Partner Agreement
Company signs sales and marketing agreement for rapid molecular test for TB.
Tuesday, March 06, 2012
Epistem Holdings Announce £2.8 Million Cash Placing
Company to use the net proceeds to accelerate the development and commercialization of Genedrive™.
Tuesday, November 29, 2011
Epistem Announces Partnership with The University of Manchester
Partnership will allow Epistem to expand its wound healing models range.
Monday, November 14, 2011
Epistem Announces Collaboration With Sanofi-Aventis
3 year collaboration to provide discovery through to clinical biomarker support to oncology programmes of sanofi-aventis and its affiliates.
Monday, March 21, 2011
Epistem Presents its new Ex Vivo Plucked Hair Biomarker Assay at EORTC-NCI-AACR Symposium
New method for maintaining plucked human hairs ex vivo, and treating with therapeutic agents to obtain information on the cellular response to drug treatment.
Friday, November 19, 2010
EpiStem Awarded Further Long Term Funding for NIH Biodefence Programme
The Company has been reappointed for up to five years to provide preclinical testing services as a subcontractor.
Wednesday, November 10, 2010
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!